Atlas Trials

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT03043599 · COMPLETED

Trial details

NCT number
NCT03043599
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer
Start date
2017-02-13
Primary completion
2018-10-26
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.